Cargando…
Vitexicarpin Acts as a Novel Angiogenesis Inhibitor and Its Target Network
Vitexicarpin (VIT) isolated from the fruits of Vitex rotundifolia has shown antitumor, anti-inflammatory, and immunoregulatory properties. This work is designed to evaluate the antiangiogenic effects of VIT and address the underlying action mechanism of VIT by a network pharmacology approach. The re...
Autores principales: | Zhang, Bo, Liu, Lu, Zhao, Shiwen, Wang, Xu, Liu, Liyang, Li, Shao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583114/ https://www.ncbi.nlm.nih.gov/pubmed/23476684 http://dx.doi.org/10.1155/2013/278405 |
Ejemplares similares
-
In silico and in vitro studies on the anti-cancer activity of artemetin, vitexicarpin and penduletin compounds from Vitex negundo
por: Vo, Giau Van, et al.
Publicado: (2022) -
Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification
por: Zhao, Shiwen, et al.
Publicado: (2010) -
Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer
por: Li, Yingying, et al.
Publicado: (2022) -
YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
por: Shao, Rong
Publicado: (2013) -
Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors
por: Weitensteiner, Sabine B., et al.
Publicado: (2013)